| Application no. and date | 17771247.8 (espacenet) (Federated) (European Patent Register), 20170324 | | Patent/reg. no. and date | DK/EP 3432861, 20230712 | | Publication date | 20190130 | | Priority no. and date | US 201662312473 P, 20160324 | | EP pub. no. and date |
EP 3432861 20190130 | | Effective date | | | Applicant/owner | Elgan Pharma Ltd., New Generation Technologies NGT3
13 Wadi El-Haj Street
1711102 Nazareth, IL | | Applicant ref. no. | | | Inventor | ATAROT, Tal, 1 Ha'tzivoni Street
4061401 Tel-Mond, IL,
OLSHANSKY, Michal, 12 Bavli Street
6233112 Tel-Aviv, IL | | Representative | | | Opponent | | | IPC Class | A61K 38/28 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61K 9/02 (2006.01) , A61K 9/14 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 1/14 (2006.01) , C07K 14/62 (2006.01) | | Title | USE OF INSULIN FOR PROMOTING GASTRIC EMPTYING | | Int. application no. | US2017024053 | | Int. publication no. | WO2017165789 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
